PubMed Health⌕ Search

Biomedical subjects

A P Høyer

Publications and source records attributed to A P Høyer.

10 recordsLinked to original sources
PubMed2001

Organochlorine exposures influence on breast cancer risk and survival according to estrogen receptor status: a Danish cohort-nested case-control study.

BACKGROUND: The relationship between breast cancer and organochlorine exposure is controversial and complex. As estrogen receptor positive and negative breast cancer may represent different entities of the disease, this study was undertaken to evaluate organochlorines influence on breast cancer risk and survival according to receptor status. METHODS: The background material stems from the Copenhagen City Heart Study (Denmark 1976-78). The breast cancer risk was investigated in a cohort nested case-control design including 161 cases and twice as many breast cancer free controls. The cases served as a cohort in the survival analysis. Serum organochlorine concentrations were determined by gaschromotography. RESULTS: The observed increased breast cancer risk associated with exposure to dieldrin derived from women who developed an estrogen receptor negative (ERN) tumor (Odds ratio [OR] I vs. IV quartile, 7.6, 95% confidence interval [95% CI] 1.4-46.1, p-value for linear trend 0.01). Tumors in women with the highest dieldrin serum level were larger and more often spread at the time of diagnosis than ERP tumors. The risk of dying was for the remaining evaluated compounds higher among patients with ERP breast cancer when compared to those with ERN. In the highest quartile of polychlorinated biphenyls (SigmaPCB) it was more than 2-fold increased (Relative risk [RR] I vs. IV quartile, 2.5, 95% CI 1.1-5.7), but no dose-response relation was apparent. CONCLUSION: The results do not suggest that exposure to potential estrogenic organochlorines leads to development of an ERP breast cancer. A possible adverse effect on prognosis of hormone-responsive breast cancers needs to be clarified.

Adult↗
PubMed2000

Organochlorine exposure and breast cancer survival.

Recent research suggests that exposure to organochlorines, such as dieldrin that possess estrogenic properties, may increase the risk of breast cancer by promoting growth of malignant cells. Whether this potential also affects malignant cells not eradicated by treatment, and thereby survival, is unknown. To evaluate this blood samples from female participants in the Copenhagen City Heart Study, Denmark, were analyzed for organochlorines. A total of 195 breast cancer cases, who each provided two blood samples that were taken in 1976-78 and 1981-83, respectively, were included in the survival analysis. Dieldrin had a significant adverse effect on overall survival and breast cancer specific survival (RR, 2.78, 95% CI, 1. 38-5.59, P trend < 0.01; RR, 2.61, 95% CI, 0.97-7.01, P trend < 0. 01). This association was strengthened when exposure was assessed as the average serum concentration of the two measurements. These findings suggest that past exposure to estrogenic organochlorines such as dieldrin may not only affect the risk of developing breast cancer but also the survival.

Adult↗
PubMed2000

[Organochlorine compounds and breast cancer--is there a connection between environmental pollution and breast cancer?].

Some organochlorine compounds may have weak oestrogenic effects and are therefore suspected of increasing the risk of breast cancer. The risk of breast cancer was assessed prospectively in relation to the serum concentration of several organochlorines. In all 240 women, who developed breast cancer between 1976 and 1993 were together with 477 breast cancer-free controls enrolled in a cohort-nested case-control study. The serum dieldrin concentration was associated with a significantly increased dose-related risk of breast cancer (Odds Ratio 2.05; 95% confidence interval 1.17-3.57; p for trend 0.01). There was no overall association between risk of breast cancer and DDT or polychlorinated biphenyls. The results support the hypothesis that exposure to oestrogenic organochlorines may increase the risk of breast cancer.

Breast Neoplasms↗
PubMed2000

Repeated measurements of organochlorine exposure and breast cancer risk (Denmark).

OBJECTIVE: To prospectively evaluate if repeated measurements of organochlorine exposure provide a more precise measure of breast cancer risk. METHODS: In the Copenhagen City Heart Study (CCHS) participants donated blood twice, in 1976-1978 and 1981 1983. Information on breast cancer risk factors was obtained through standardized questionnaires. A cohort nested case-control study of 155 cases and 274 matched breast cancer-free controls who had participated in both CCHS examinations was conducted. The average serum organochlorine concentration over the course of the two examinations was used, testing a possible association between organochlorine exposure and breast cancer risk. RESULTS: A high serum concentration of p,p'-DDT over the course of the two examinations was associated with a more than three-fold significantly increased risk of breast cancer, and a dose-response relationship was apparent. Furthermore, the risk of breast cancer increased with increasing serum concentrations of PCB congener 118 and 138 and the total amount of DDT isomers (sigmaDDT), but the trends were not significant. CONCLUSION: This study provides new evidence of the adverse effect of some organochlorines on breast cancer risk. Furthermore, repeated assessment of exposure during a relevant time period may provide a more precise risk estimate than a single measurement.

Adult↗
PubMed1998

Organochlorine exposure and risk of breast cancer.

BACKGROUND: Some organochlorine compounds may have weak oestrogenic effects and are, therefore, suspected of increasing the risk of breast cancer. We assessed prospectively the risk of breast cancer in relation to serum concentrations of several organochlorine compounds. METHODS: In 1976, serum samples from 7712 women were obtained from participants in the Copenhagen City Heart Study as part of physical examinations and interviews about lifestyle factors. During 17 years of follow-up, 268 women developed invasive breast cancer. Each woman with breast cancer was matched with two breast-cancer-free women from the remaining cohort. We analysed in 1996-97 the serum samples from 240 women with breast cancer and 477 controls. FINDINGS: Dieldrin was associated with a significantly increased dose-related risk of breast cancer (adjusted odds ratio 2.05 [95% CI 1.17-3.57], p for trend 0.01). Beta-hexachlorocyclohexane increased risk slightly but not significantly (p for trend 0.24). There was no overall association between risk of breast cancer and p,p'-dichlorodiphenyltrichloroethane or metabolites or for polychlorinated biphenyls. Exclusion of women with breast cancer diagnosed within 5 years of blood sampling strengthened the result for dieldrin, but did not affect the other results. INTERPRETATION: These findings support the hypothesis that exposure to xeno-oestrogens may increase the risk of breast cancer.

Adult↗
PubMed1995

Breast cancer in NSW women: a shift in tumour size.

OBJECTIVE: To determine whether there has been an increase in the proportion of small (< 1 cm in size) and localised breast cancers in women aged 50-69 (the group actively recruited to mammographic screening) compared with women aged 40-49. DESIGN: Cases of invasive breast cancer in women aged 40-69 notified to the NSW Central Cancer Registry in 1986, 1989 and 1992 were included. Tumour sizes were determined from histopathology reports. RESULTS: A higher percentage of breast cancers were under 1 cm in size in 1992 (10%) than in 1986 and 1989 (7%). The increase in the percentage of small breast cancers was statistically significant in women aged 50-69 (chi 2 for linear trend, 7.9; P = 0.005) but not in those aged 40-49 (chi 2 for linear trend, 2.5; P = 0.12). Slightly more than half the breast cancers (53%) in 1992 were localised to the breast, representing an increase from 49% in both 1986 and 1989. This increase was also statistically significant in women aged 50-69 (chi 2 for linear trend, 3.9; P = 0.05) but not in those aged 40-49 (chi 2 for linear trend, 1.4; P = 0.24). CONCLUSIONS: Breast cancers in 1986, 1989 and 1992 showed a moderately strong shift to smaller tumours and localised disease in women aged 50-69. As women of this age group were targeted by mammographic screening, the widespread availability of mammography may explain this shift.

Adult↗
PubMed1992

Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women.

The association between serum lipids and breast cancer risk was investigated in a cohort of 5,207 Danish women, who participated in The Glostrup Population Studies between 1964 and 1986. During four to 26 years of follow-up, 51 incident cases of breast cancer were identified by linkage to the Danish Cancer Registry. At the time of lipid measurement, the women were between 30 and 80 years of age. An inverse association was found between serum high-density lipoprotein (HDL) cholesterol and risk of breast cancer, which was not changed by adjustment for potential confounders such as social class, age at menarche and menopause, number of full-term pregnancies, body mass index, or alcohol and coffee consumption. The relative risk was 0.3 (95 percent confidence interval = 0.1-0.8) for women in the highest quartile of serum HDL-cholesterol compared with women in the lowest quartile and the relation displayed a significant negative trend (P = 0.01). For serum triglycerides there was a suggestion of a positive association with breast cancer incidence, but the trend was not significant (P = 0.06). No relationship between total serum cholesterol or low-density lipoprotein cholesterol and risk of breast cancer was observed. Risk estimates for well known breast cancer risk factors such as social class, age at menopause, number of full-term pregnancies, and obesity were in the directions expected.

Adult↗